Trial Profile
Association Between Beta-1 and Beta-2 Adrenergic Receptor Polymorphism and Beta-blocker(Bisoprolol) Therapy in Heart Failure.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Bisoprolol (Primary)
- Indications Chronic heart failure
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms ABBA
- Sponsors Merck KGaA
- 13 Mar 2012 Additional lead trial centre/investigator identified as reported by ClinicalTrials.gov.
- 06 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Oct 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.